Oceanpayment\'s new Mastercard-powered virtual commercial credit card aims to help reduce the operational costs of multi-currency accounts while improving conversion rates
Oceanpayment\'s new Mastercard-powered virtual commercial credit card aims to help reduce the operational costs of multi-currency accounts while improving conversion rates
InCred Group Acquires Arrow Capital DIFC, Expanding Its Footprint in the Middle East
DUBAI,UAE and SINGAPORE,Feb. 17,2025-- The diversified financial services firm \'InCred Group\' today announced the acquisition of Arrow Capital (DIFC) Limited,a leading boutique financial services f
Ricoh selected as a member of the Sustainability Yearbook 2025 by S&P Global
TOKYO,Feb. 17,2025--Ricoh today announced it has been selected as a member of the Sustainability Yearbook 2025,with a score within the top 10%* in its industry,by S&P Global,an American company a
Per Franzén appointed new CEO of EQT AB as of May 2025
The Board of Directors of EQT AB ("EQT") has appointed Per Franzén as new CEO and Managing Partner,effective as of the Annual Shareholders\' Meeting on 27 May 2025. During this transi
Enhancing McDonald\'s China digital ordering system to efficiently manage both regular peak times and promotional surges
Fosun International Continues to be Recognized in the S&P Global's Sustainability Yearbook 2025
HONG KONG,Feb. 14,2025-- On 12 February 2025,S&P Global released the Sustainability Yearbook 2025.Fosun International Limited (HKEX Stock Code: 00656,"Fosun International") was successfu
SHANGHAI,Feb. 14,2025-- The HEROESPORTS Asian Champions League (ACL),Asia\'s premier multi-title esports tournament hosted by Asia\'s leading esports company Hero Esports,has announced that champions
ATFX Attends ACBC NSW Chinese New Year Gala 2025, Strengthening Australia-China Business Ties
SYDNEY,Feb. 14,2025-- ATFX was honored to participate in the ACBC NSW Chinese New Year Gala 2025,a premier event that brings together business and government leaders to celebrate the strong economic r
SHANGHAI and NANJING,China and SAN JOSE,Calif.,Feb. 14,2025-- IASO Biotherapeutics ("IASO Bio"),a biopharmaceutical company focused on the discovery,development,manufacturing,and commerciali
NSFOCUS ISOP platform responds to emerging threats and evolving customer requirements,enhances operational efficiency,and allows for customization to meet diverse customer needs.